chorioretinopathy

Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration

The MHRA have issued information on central serous chorioretinopathy, a retinal disorder that has been linked to the systemic use of corticosteroids. Recently, it has also been reported after local administration of corticosteroids via inhaled and intranasal, epidural, intra-articular, topical dermal, and periocular routes.

Healthcare professionals should advise patients to report any blurred vision or other visual disturbances during corticosteroid treatment and consider referral to an ophthalmologist for evaluation of possible causes if a patient presents with vision problems.